nifedipine has been researched along with interleukin-8 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bacon, KB; Camp, RD; Westwick, J | 1 |
| Aperia, A; Bäckhed, F; Brismar, H; Celsi, G; Jahnukainen, T; Laestadius, A; Normark, S; Richter-Dahlfors, A; Söderblom, T; Uhlén, P | 1 |
| Bernardo, J; Hasturk, H; Herrmann, JM; Kantarci, A; Long, H; Simons, ER; Van Dyke, TE; Wray, LV | 1 |
| Makhlouf, MA; Simhan, HN | 1 |
| Berthier, A; Bouchot, A; Corcos, L; Desrumaux, C; Lemaire-Ewing, S; Lizard, G; Logette, E; Monier, S; Néel, D; Prunet, C; Raveneau, M; Rébé, C; Royer, MC | 1 |
| Dong, B; Matsumura, F; Sciullo, EM; Vogel, CF | 1 |
| Ding, S; Du, J; Hu, M; Huang, J; Lu, J; Shen, B; Yin, S; Zhang, J | 1 |
7 other study(ies) available for nifedipine and interleukin-8
| Article | Year |
|---|---|
Potent and specific inhibition of IL-8-, IL-1 alpha- and IL-1 beta-induced in vitro human lymphocyte migration by calcium channel antagonists.
Topics: Calcium Channel Blockers; Chemotactic Factors; Chemotaxis, Leukocyte; Dihydropyridines; Diltiazem; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Interleukin-1; Interleukin-8; Interleukins; Kinetics; Lymphocytes; Nifedipine; Recombinant Proteins; Verapamil | 1989 |
Alpha-haemolysin of uropathogenic E. coli induces Ca2+ oscillations in renal epithelial cells.
Topics: Animals; Bacterial Proteins; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Epithelial Cells; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Estrenes; Female; Hemolysin Proteins; Humans; Interleukin-6; Interleukin-8; Kidney; Nifedipine; Pyelonephritis; Pyrrolidinones; Rats; Rats, Sprague-Dawley | 2000 |
Simultaneous measurements of cytoplasmic Ca2+ responses and intracellular pH in neutrophils of localized aggressive periodontitis (LAP) patients.
Topics: Aggressive Periodontitis; Calcium; Cytokines; Cytoplasm; Diltiazem; Dose-Response Relationship, Drug; Humans; Hydrogen-Ion Concentration; Imidazoles; Interleukin-8; Intracellular Fluid; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Nifedipine; Substance P; Time Factors; Verapamil | 2005 |
Effect of tocolytics on interleukin-8 production by human amniotic and decidual cells.
Topics: Amnion; Cells, Cultured; Decidua; Endotoxins; Female; Humans; Interleukin-8; Magnesium Sulfate; Nifedipine; Pregnancy; Terbutaline; Tocolytic Agents | 2006 |
7beta-Hydroxycholesterol and 25-hydroxycholesterol-induced interleukin-8 secretion involves a calcium-dependent activation of c-fos via the ERK1/2 signaling pathway in THP-1 cells: oxysterols-induced IL-8 secretion is calcium-dependent.
Topics: Calcium; Calcium Channel Blockers; Cell Line; Gene Expression; Humans; Hydroxycholesterols; Interleukin-8; Lipoproteins, LDL; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Monocytes; Nifedipine; Proto-Oncogene Proteins c-fos; RNA, Messenger; Transcription Factor AP-1; Verapamil | 2009 |
Characterization of the pattern of the nongenomic signaling pathway through which TCDD-induces early inflammatory responses in U937 human macrophages.
Topics: Arachidonic Acid; Aryl Hydrocarbon Receptor Nuclear Translocator; Cell Line; Cyclooxygenase 2; Enzyme Activation; Humans; Inflammation; Interleukin-8; Macrophages; Nifedipine; Phospholipases A2, Cytosolic; Polychlorinated Dibenzodioxins; Pyrimidines; Receptors, Aryl Hydrocarbon; RNA, Messenger; Signal Transduction; Tumor Necrosis Factor-alpha; U937 Cells; Up-Regulation | 2009 |
Inflammatory cytokines tumour necrosis factor-α and interleukin-8 enhance airway smooth muscle contraction by increasing L-type Ca
Topics: Animals; Calcium; Calcium Channels, L-Type; Extracellular Space; Gene Expression Regulation; Inflammation; Interleukin-8; Male; Mice; Muscle Contraction; Muscle, Smooth; Nifedipine; Potassium; Trachea; Tumor Necrosis Factor-alpha; Verapamil | 2019 |